| pubmed-article:11834904 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11834904 | lifeskim:mentions | umls-concept:C0005684 | lld:lifeskim |
| pubmed-article:11834904 | lifeskim:mentions | umls-concept:C0040083 | lld:lifeskim |
| pubmed-article:11834904 | lifeskim:mentions | umls-concept:C0058126 | lld:lifeskim |
| pubmed-article:11834904 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11834904 | pubmed:dateCreated | 2002-2-8 | lld:pubmed |
| pubmed-article:11834904 | pubmed:abstractText | Thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) levels in transitional cell carcinoma of the bladder resected from 38 patients were examined by ELISA. TP levels in high-grade and invasive cancer were significantly higher than those in low-grade and superficial cancer, respectively. No significant differences in the DPD levels were observed among grades and stages, but the DPD/TP ratio was significantly lower in grade 3 tumor than in grade 1. These results demonstrated that 5'-deoxy-5-fluorouridine seemed to be useful for managing patients with grade 3 cancer. The present study also suggested that we might be able to exclude cases of bladder cancer in which 5-fluorouracil group medicines would be inappropriate candidates in treatment options by measuring both TP and DPD levels in the tumor. | lld:pubmed |
| pubmed-article:11834904 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11834904 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11834904 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11834904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11834904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11834904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11834904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11834904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11834904 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11834904 | pubmed:issn | 0042-1138 | lld:pubmed |
| pubmed-article:11834904 | pubmed:author | pubmed-author:IizumiTatsuoT | lld:pubmed |
| pubmed-article:11834904 | pubmed:author | pubmed-author:HariuKyouichi... | lld:pubmed |
| pubmed-article:11834904 | pubmed:author | pubmed-author:SatoMikaM | lld:pubmed |
| pubmed-article:11834904 | pubmed:author | pubmed-author:SatoSatoshiS | lld:pubmed |
| pubmed-article:11834904 | pubmed:author | pubmed-author:ShimizuHirofu... | lld:pubmed |
| pubmed-article:11834904 | pubmed:author | pubmed-author:TomomasaHiros... | lld:pubmed |
| pubmed-article:11834904 | pubmed:author | pubmed-author:UmedaTakashiT | lld:pubmed |
| pubmed-article:11834904 | pubmed:copyrightInfo | Copyright 2002 S. Karger AG, Basel | lld:pubmed |
| pubmed-article:11834904 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11834904 | pubmed:volume | 68 | lld:pubmed |
| pubmed-article:11834904 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11834904 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11834904 | pubmed:pagination | 122-5 | lld:pubmed |
| pubmed-article:11834904 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11834904 | pubmed:meshHeading | pubmed-meshheading:11834904... | lld:pubmed |
| pubmed-article:11834904 | pubmed:meshHeading | pubmed-meshheading:11834904... | lld:pubmed |
| pubmed-article:11834904 | pubmed:meshHeading | pubmed-meshheading:11834904... | lld:pubmed |
| pubmed-article:11834904 | pubmed:meshHeading | pubmed-meshheading:11834904... | lld:pubmed |
| pubmed-article:11834904 | pubmed:meshHeading | pubmed-meshheading:11834904... | lld:pubmed |
| pubmed-article:11834904 | pubmed:meshHeading | pubmed-meshheading:11834904... | lld:pubmed |
| pubmed-article:11834904 | pubmed:meshHeading | pubmed-meshheading:11834904... | lld:pubmed |
| pubmed-article:11834904 | pubmed:meshHeading | pubmed-meshheading:11834904... | lld:pubmed |
| pubmed-article:11834904 | pubmed:meshHeading | pubmed-meshheading:11834904... | lld:pubmed |
| pubmed-article:11834904 | pubmed:meshHeading | pubmed-meshheading:11834904... | lld:pubmed |
| pubmed-article:11834904 | pubmed:meshHeading | pubmed-meshheading:11834904... | lld:pubmed |
| pubmed-article:11834904 | pubmed:meshHeading | pubmed-meshheading:11834904... | lld:pubmed |
| pubmed-article:11834904 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11834904 | pubmed:articleTitle | Thymidine phosphorylase and dihydropyrimidine dehydrogenase in bladder cancer. | lld:pubmed |
| pubmed-article:11834904 | pubmed:affiliation | Department of Urology, Teikyo University School of Medicine, Tokyo, Japan. urology@med.teikyo-u.ac.jp | lld:pubmed |
| pubmed-article:11834904 | pubmed:publicationType | Journal Article | lld:pubmed |
